Cargando…
Somatostatin receptors in congenital hyperinsulinism: Biology to bedside
Congenital hyperinsulinism (CHI), although a rare disease, is an important cause of severe hypoglycemia in early infancy and childhood, causing preventable morbidity and mortality. Prompt diagnosis and appropriate treatment is necessary to prevent hypoglycaemia mediated brain damage. At present, the...
Autores principales: | van Albada, Mirjam E., Mohnike, Klaus, Dunne, Mark J., Banerjee, Indi, Betz, Stephen F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552539/ https://www.ncbi.nlm.nih.gov/pubmed/36237195 http://dx.doi.org/10.3389/fendo.2022.921357 |
Ejemplares similares
-
Syndromic forms of congenital hyperinsulinism
por: Zenker, Martin, et al.
Publicado: (2023) -
Delayed Resolution of Feeding Problems in Patients With Congenital Hyperinsulinism
por: Worth, Chris, et al.
Publicado: (2020) -
Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism
por: Banerjee, Indraneel, et al.
Publicado: (2016) -
Integration of genomic analysis and transcript expression of ABCC8 and KCNJ11 in focal form of congenital hyperinsulinism
por: Wieland, Ilse, et al.
Publicado: (2022) -
Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism
por: Avatapalle, Hima Bindu, et al.
Publicado: (2013)